84 related articles for article (PubMed ID: 25554586)
1. Report of new haplotype for ABCC2 gene: rs17222723 and rs8187718 in cis.
Pratt VM; Beyer BN; Koller DL; Skaar TC; Flockhart DA; Levy KD; Vance GH
J Mol Diagn; 2015 Mar; 17(2):201-5. PubMed ID: 25554586
[TBL] [Abstract][Full Text] [Related]
2. Influence of genetic polymorphisms on intestinal expression and rifampicin-type induction of ABCC2 and on bioavailability of talinolol.
Haenisch S; May K; Wegner D; Caliebe A; Cascorbi I; Siegmund W
Pharmacogenet Genomics; 2008 Apr; 18(4):357-65. PubMed ID: 18334920
[TBL] [Abstract][Full Text] [Related]
3. ABCC2 polymorphisms and haplotype are associated with drug resistance in Chinese epileptic patients.
Qu J; Zhou BT; Yin JY; Xu XJ; Zhao YC; Lei GH; Tang Q; Zhou HH; Liu ZQ
CNS Neurosci Ther; 2012 Aug; 18(8):647-51. PubMed ID: 22630058
[TBL] [Abstract][Full Text] [Related]
4. Functional defect caused by the 4544G>A SNP in ABCC2: potential impact for drug cellular disposition.
Elens L; Tyteca D; Panin N; Courtoy P; Lison D; Demoulin JB; Haufroid V
Pharmacogenet Genomics; 2011 Dec; 21(12):884-93. PubMed ID: 22027652
[TBL] [Abstract][Full Text] [Related]
5. The ABCC2 c.-24C>T polymorphism increases the risk of resistance to antiepileptic drugs: A meta-analysis.
Qian L; Fang S; Yan YL; Zeng SS; Xu ZJ; Gong ZC
J Clin Neurosci; 2017 Mar; 37():6-14. PubMed ID: 27816260
[TBL] [Abstract][Full Text] [Related]
6. Association of the multidrug-resistance-associated protein gene (ABCC2) variants with intrahepatic cholestasis of pregnancy.
Sookoian S; Castaño G; Burgueño A; Gianotti TF; Pirola CJ
J Hepatol; 2008 Jan; 48(1):125-32. PubMed ID: 17997497
[TBL] [Abstract][Full Text] [Related]
7. Impact of ABCC2 genotype on antiepileptic drug response in Caucasian patients with childhood epilepsy.
Ufer M; von Stülpnagel C; Muhle H; Haenisch S; Remmler C; Majed A; Plischke H; Stephani U; Kluger G; Cascorbi I
Pharmacogenet Genomics; 2011 Oct; 21(10):624-30. PubMed ID: 21799461
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms of MRP2 (ABCC2) are associated with susceptibility to nonalcoholic fatty liver disease.
Sookoian S; Castaño G; Gianotti TF; Gemma C; Pirola CJ
J Nutr Biochem; 2009 Oct; 20(10):765-70. PubMed ID: 18926681
[TBL] [Abstract][Full Text] [Related]
9. Genetic association analysis of transporters identifies ABCC2 loci for seizure control in women with epilepsy on first-line antiepileptic drugs.
Grover S; Gourie-Devi M; Bala K; Sharma S; Kukreti R
Pharmacogenet Genomics; 2012 Jun; 22(6):447-65. PubMed ID: 22565165
[TBL] [Abstract][Full Text] [Related]
10. Genetic variants may play an important role in mRNA-miRNA interaction: evidence for haplotype-dependent downregulation of ABCC2 (MRP2) by miRNA-379.
Werk AN; Bruckmueller H; Haenisch S; Cascorbi I
Pharmacogenet Genomics; 2014 Jun; 24(6):283-91. PubMed ID: 24743544
[TBL] [Abstract][Full Text] [Related]
11. Selected ABCB1, ABCB4 and ABCC2 polymorphisms do not enhance the risk of drug-induced hepatotoxicity in a Spanish cohort.
Ulzurrun E; Stephens C; Ruiz-Cabello F; Robles-Diaz M; Saenz-López P; Hallal H; Soriano G; Roman E; Fernandez MC; Lucena MI; Andrade RJ
PLoS One; 2014; 9(4):e94675. PubMed ID: 24732756
[TBL] [Abstract][Full Text] [Related]
12. A systematic review and meta-analysis of the role of ABCC2 variants on drug response in patients with epilepsy.
Grover S; Kukreti R
Epilepsia; 2013 May; 54(5):936-45. PubMed ID: 23506516
[TBL] [Abstract][Full Text] [Related]
13. Influence of polymorphisms of ABCB1 and ABCC2 on mRNA and protein expression in normal and cancerous kidney cortex.
Haenisch S; Zimmermann U; Dazert E; Wruck CJ; Dazert P; Siegmund W; Kroemer HK; Warzok RW; Cascorbi I
Pharmacogenomics J; 2007 Feb; 7(1):56-65. PubMed ID: 16788565
[TBL] [Abstract][Full Text] [Related]
14. Lack of association between ABCC2 gene variants and treatment response in epilepsy.
Hilger E; Reinthaler EM; Stogmann E; Hotzy C; Pataraia E; Baumgartner C; Zimprich A; Zimprich F
Pharmacogenomics; 2012 Jan; 13(2):185-90. PubMed ID: 22256867
[TBL] [Abstract][Full Text] [Related]
15. Wilson disease, ABCC2 c.3972C > T polymorphism and primary liver cancers: suggestions from a familial cluster.
Brandi G; Rizzo A; Deserti M; Relli V; Indio V; Bin S; Pariali M; Palloni A; De Lorenzo S; Tovoli F; Tavolari S
BMC Med Genet; 2020 Nov; 21(1):225. PubMed ID: 33208122
[TBL] [Abstract][Full Text] [Related]
16. Impact of ABCC2 1249G>A and -24C>T Polymorphisms on Lacosamide Efficacy and Plasma Concentrations in Uygur Pediatric Patients With Epilepsy in China.
Zhao T; Li HJ; Zhang HL; Feng J; Yu J; Wang TT; Sun Y; Yu LH
Ther Drug Monit; 2023 Feb; 45(1):117-125. PubMed ID: 36253887
[TBL] [Abstract][Full Text] [Related]
17. Association of the c.3972C>T variant of the multidrug resistance-associated protein 2 Gene (MRP2/ABCC2) with susceptibility to bile duct cancer.
Hoblinger A; Grunhage F; Sauerbruch T; Lammert F
Digestion; 2009; 80(1):36-9. PubMed ID: 19451719
[TBL] [Abstract][Full Text] [Related]
18. Impact of ABCC2 haplotypes on transcriptional and posttranscriptional gene regulation and function.
Laechelt S; Turrini E; Ruehmkorf A; Siegmund W; Cascorbi I; Haenisch S
Pharmacogenomics J; 2011 Feb; 11(1):25-34. PubMed ID: 20351751
[TBL] [Abstract][Full Text] [Related]
19. Functional characterization of ABCC2 promoter polymorphisms and allele-specific expression.
Nguyen TD; Markova S; Liu W; Gow JM; Baldwin RM; Habashian M; Relling MV; Ratain MJ; Kroetz DL
Pharmacogenomics J; 2013 Oct; 13(5):396-402. PubMed ID: 22664480
[TBL] [Abstract][Full Text] [Related]
20. Functional characterization of protein variants of the human multidrug transporter ABCC2 by a novel targeted expression system in fibrosarcoma cells.
Arlanov R; Porter A; Strand D; Brough R; Karpova D; Kerb R; Wojnowski L; Schwab M; Lang T
Hum Mutat; 2012 Apr; 33(4):750-62. PubMed ID: 22290738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
